thiophenes has been researched along with Adrenal Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Jonghe, S; Feyen, B; Geys, H; Johnson, MD; Mamidi, RN; Marien, D; Proctor, J; Vinken, P; Wynant, I | 1 |
Fottner, C; Weber, MM | 1 |
1 review(s) available for thiophenes and Adrenal Cancer
Article | Year |
---|---|
[The latest developments in endocrinology 2004/2005].
Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed | 2006 |
1 other study(ies) available for thiophenes and Adrenal Cancer
Article | Year |
---|---|
Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin.
Topics: Adrenal Gland Neoplasms; Animals; Canagliflozin; Carcinogenesis; Carcinogenicity Tests; Dose-Response Relationship, Drug; Glucosides; Kidney Neoplasms; Kidney Tubules; Leydig Cell Tumor; Male; Pheochromocytoma; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship; Testicular Neoplasms; Thiophenes | 2014 |